Issue 11, 2009

In vivosiRNA delivery with dendritic poly(l-lysine) for the treatment of hypercholesterolemia

Abstract

Intravenous delivery of apolipoprotein B-specific siRNA with a sixth-generation of dendritic poly(L-lysine) (KG6) resulted in siRNA-mediated knockdown of ApoB in healthy C57BL/6 mice without hepatotoxicity, and with a significant reduction of serum low-density lipoprotein cholesterol in apolipoprotein E-deficient mice.

Graphical abstract: In vivo siRNA delivery with dendritic poly(l-lysine) for the treatment of hypercholesterolemia

Supplementary files

Article information

Article type
Communication
Submitted
30 Jan 2009
Accepted
12 Aug 2009
First published
21 Aug 2009

Mol. BioSyst., 2009,5, 1306-1310

In vivo siRNA delivery with dendritic poly(L-lysine) for the treatment of hypercholesterolemia

K. Watanabe, M. Harada-Shiba, A. Suzuki, R. Gokuden, R. Kurihara, Y. Sugao, T. Mori, Y. Katayama and T. Niidome, Mol. BioSyst., 2009, 5, 1306 DOI: 10.1039/B900880B

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements